#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal squamous cell carcinoma Transitional cell cancer of the renal pelvis and ureter Hypereosinophilic syndrome Chronic lymphocytic leukaemia recurrent Skin cancer Pulmonary arterial hypertension Parkinson's disease Follicular lymphoma Paroxysmal nocturnal haemoglobinuria Spinal cord injury cervical Growth hormone deficiency Congenital absence of bile ducts Non-Hodgkin's lymphoma unspecified histology indolent Multiple system atrophy Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Treatment Pulmonary sarcoidosis Hepatic angiosarcoma – Treatment Angiosarcoma recurrent – Diagnostics Glomerulonephritis membranous – Diagnostics Netherton’s syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Diagnostics Glomerulonephritis membranous – Basic Information Biotinidase deficiency – Basic Information Haemophilia A with anti factor VIII – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vancomycin Casirivimab Zagociguat Specific Nucleic Acid Sna-Her2 Marstacimab Blinatumomab Cedazuridine Rbl016.2 Tazemetostat Specific Nucleic Acid Sna-Her1 Iph5201 HUPERZINE A Gskvx000000014593 Ribitol Eltrombopag Erythromycin Lactobionate L-Tryptophan AZD0022 Rp1 Verapamil More therapies…

    Learn about Your Condition

    Oesophageal atresia Von Hippel-Lindau disease Aortic aneurysm Ovarian cancer metastatic Psychological trauma Hyperglycaemia Radicular pain Glomerulonephritis membranous Respiratory tract infection Erosive oesophagitis Hidradenitis Fibrosarcoma metastatic Neuromuscular scoliosis Albright's disease Lung adenocarcinoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder

    Not recruiting

    3 1
    Investigated Drugs:
    • LY3537031
    Belgium Germany

  • Testing sublingual immunotherapy with dermatophagoides pteronyssinus extract for adults with moderate to severe house dust mite allergy

    Not recruiting

    4 1
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus Extract
    Germany Spain

  • A Study of Inhaled Fexlamose for Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • 6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE
    Bulgaria Poland Spain

  • Testing IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • IDOR-1117-2520C
    Bulgaria Romania

  • A study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy

    Not recruiting

    2 1
    Investigated Drugs:
    • Aprepitant
    Hungary Poland Spain

  • Study of Sildenafil for Men with Erectile Dysfunction to Evaluate Their Ability to Safely Decide on Using This Medication Independently

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Erectile dysfunction
    Investigated Drugs:
    • Sildenafil Citrate
    Poland
Previous Page
1 … 938 939 940 941 942 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!